Skip to main content

Autonomic Dysfunction Versus Neuropathy

  • Chapter
  • First Online:
Clinical Autonomic Dysfunction

Abstract

Unfortunately the “autonomic neuropathy” has inherited the misperception that it is not treatable. While this may be true due to a lack of sufficient information, it is no longer the case. This then begs the question, when does autonomic dysfunction become autonomic neuropathy. While neuropathy may now be treatable, given more information, it still leaves the physician with few therapy options. Autonomic dysfunction has more therapy options but is asymptomatic. In this chapter, we will discuss a recent study to highlight the difference between autonomic neuropathy and dysfunction, and provide another approach to differentiating stages of autonomic decline. There is actually two schools of thought: five stages of decline or six. The six stages of decline include a brief second stage which is early in the progression. It is not often observed. However, it may provide the insight needed to understand the etiology of high BP or hypertension secondary to many chronic diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Vinik A, Mehrabyan A. Diagnosis and management of diabetic autonomic neuropathy. Compr Ther. 2003;29(2–3):130–45.

    Google Scholar 

  2. Vinik AI. The conductor of the autonomic orchestra. Front Endocrinol. 2012;3(71):1–13.

    Google Scholar 

  3. Litchman JH, Bigger Jr JT, Blumenthal JA, et al. Depression and coronary heart disease recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Psychiatric Association. Circulation. 2008;118:1768–75.

    Article  Google Scholar 

  4. Vinik AI, Maser RE, Ziegler D. Autonomic imbalance: prophet of doom or scope for hope? Diabet Med. 2011;28:643–51.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  5. Pop-Busui R, Evans GW, Gerstein HC, Fonseca V, Fleg JL, Hoogwerf BJ, Genuth MS, Grimm RH, Corson MA, Prineas R, ACCORD Study Group. Effects of cardiac autonomic dysfunction on mortality risk in the action to control cardiovascular risk in diabetes (ACCORD) trial. Diabetes Care. 2010;33:1578–84.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  6. Calles-Escandon J, Lovato L, Simons-Morton D, Kendell D, Pop-Busui R, Cohen R, Bonds D, Fonseca V, Ismail-Beigi F, Banerji M, Failor A, Hamilton B. Effect of intensive compared with standard glycemia treatment strategies on mortality by baseline subgroup characteristics. Diabetes Care. 2010;33:721–7.

    Article  PubMed Central  PubMed  Google Scholar 

  7. Tesfaye S, Boulton AJ, Dyck PJ, Freeman R, Horowitz M, Kempler P, Lauria G, Malik RA, Spallone V, Vinik A, Bernardi L, Valensi P, Toronto Diabetic Neuropathy Expert Group. Diabetic neuropathies update on definitions diagnostic criteria estimation of severity and treatments. Diabetes Care. 2010;33:2285–93.

    Article  PubMed Central  PubMed  Google Scholar 

  8. DePace NL, Mears JP, Yayac M, Colombo J. Cardiac autonomic testing and diagnosing heart disease. “A clinical perspective.” Heart International. Accepted. 2014.

    Google Scholar 

  9. DePace NL, Mears JP, Yayac M, Colombo J. Cardiac autonomic testing and treating heart disease. “A clinical perspective.” Heart International. Accepted. 2014.

    Google Scholar 

  10. Valensi P, Paries J, Attali JR, French Group for Research and Study of Diabetic Neuropathy. Cardiac autonomic neuropathy in diabetic patients: influence of diabetes duration, obesity, and microangiopathic complications–the French multicenter study. Metabolism. 2003;52:815–20.

    Article  CAS  PubMed  Google Scholar 

  11. Witte DR, Tesfaye S, Chaturvedi N, Eaton SE, Kempler P, Fuller JH, EURODIAB Prospective Complications Study Group. Risk factors for cardiac autonomic neuropathy in type 1 diabetes mellitus. Diabetologia. 2005;48:164–71.

    Article  CAS  PubMed  Google Scholar 

  12. Vinik A, Ziegler D. Diabetic cardiovascular autonomic neuropathy. Circulation. 2007;115:387–97.

    Article  PubMed  Google Scholar 

  13. Vinik AI, Nevoret ML, Casellini CM, Parson H. Diabetic neuropathy. Endocrinol Metab Clin N Am. 2013;42(4):747–87.

    Article  Google Scholar 

  14. Spallone V, Maiello MR, Morganti R, Mandica S, Frajese G. Usefulness of ambulatory blood pressure monitoring in predicting the presence of autonomic neuropathy in type I diabetic patients. J Hum Hypertens. 2007;21:381–6.

    CAS  PubMed  Google Scholar 

  15. Ziegler D, Zentai CP, Perz S, Rathmann W, Haastert B, Doring A, Meisinger C, KORA Study Group. Prediction of mortality using measures of cardiac autonomic dysfunction in the diabetic and non-diabetic population: the MONICA/KORA Augsburg cohort study. Diabetes Care. 2008;31:556–61.

    Article  PubMed  Google Scholar 

  16. Bernardi L. Clinical evaluation of arterial baroreflex activity in diabetes. Diabetes Nutr Metab. 2000;13:331–40.

    CAS  PubMed  Google Scholar 

  17. Stevens MJ, Raffel DM, Allman KC, Dayanikli F, Ficaro E, Sandford T, Wieland DM, Pfeifer MA, Schwaiger M. Cardiac sympathetic dysinnervation in diabetes: implications for enhanced cardiovascular risk. Circulation. 1998;98:961–8.

    Article  CAS  PubMed  Google Scholar 

  18. Rayner CK, Horowitz M. Gastrointestinal motility and glycemic control in diabetes: the chicken and the egg revisited? J Clin Invest. 2006;116:299–302.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  19. McCallum RW, Sarosiek I, Parkman HP, Snape W, Brody F, Wo J, Nowak T. Gastric electrical stimulation with Enterra therapy improves symptoms of idiopathic gastroparesis. Neurogastroenterol Motil. 2013;25:815–24. doi:10.1111/nmo.12185 [Epub ahead of print].

  20. Camilleri M, Parkman HP, Shafi MA, Abell TL, Gerson L, American College of Gastroenterology. Clinical guideline: management of gastroparesis. Am J Gastroenterol. 2013;108(1):18–37. doi:10.1038/ajg.2012.373; quiz 38. Epub 2012 Nov 13.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  21. Varkonyi T, Kempler P. Erectile dysfunction. In: Sinclair A, editor. Diabetes in old age. 3rd ed. New York: Wiley; 2009. p. 149–64.

    Chapter  Google Scholar 

  22. Gazzaruso C, Giordanetti S, De Amici E, Bertone G, Falcone C, Geroldi D, Fratino P, Solerte SB, Garzaniti A. Relationship between erectile dysfunction and silent myocardial ischemia in apparently uncomplicated type 2 diabetic patients. Circulation. 2004;110:22–6.

    Article  PubMed  Google Scholar 

  23. Hill SR, Fayyad AM, Jones GR. Diabetes mellitus and female lower urinary tract symptoms: a review. Neurourol Urodyn. 2008;27:362–7.

    Google Scholar 

  24. Hunter KF, Moore KN. DM-associated bladder dysfunction in the older adult. Ger Nurs. 2003;24:138–45.

    Google Scholar 

  25. Tentolouris N, Marinou K, Kokotis P, Karanti A, Diakoumopoulou E, Katsilambros N. Sudomotor dysfunction is associated with foot ulceration in diabetes. Diabet Med. 2009;26:302–5.

    Article  CAS  PubMed  Google Scholar 

  26. Spallone V, Ziegler D, Freeman R, et al. Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management. Diabetes Metab Res Rev. 2011;27:639–53.

    Article  PubMed  Google Scholar 

  27. Albers JW, Herman WH, Pop-Busui R, et al. Effect of prior intensive insulin treatment during the Diabetes Control and Complications Trial (DCCT) on peripheral neuropathy in type 1 diabetes during the Epidemiology of Diabetes Interventions and Complications (EDIC) study. Diabetes Care. 2010;33:1090–6.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  28. Maser RE, Mitchell BD, Vinik AI, et al. The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis. Diabetes Care. 2003;26:1895–901.

    Article  PubMed  Google Scholar 

  29. Ziegler D, Zentai CP, Perz S, et al. Prediction of mortality using measures of cardiac autonomic dysfunction in the diabetic and nondiabetic population: the MONICA/KORA Augsburg cohort study. Diabetes Care. 2008;31:556–61.

    Article  PubMed  Google Scholar 

  30. Lykke JA, Tarnow L, Parving HH, et al. A combined abnormality in heart rate variation and QT corrected interval is a strong predictor of cardiovascular death in type 1 diabetes. Scand J Clin Lab Invest. 2008;68:654–9.

    Article  CAS  PubMed  Google Scholar 

  31. Hage FG, Iskandrian AE. Cardiovascular imaging in diabetes mellitus. J Nucl Cardiol. 2011;18:959–65.

    Article  PubMed  Google Scholar 

  32. Vinik AI, Maser RE, Ziegler D. Neuropathy. The crystal ball for cardiovascular disease. Diabetes Care. 2010;33(7):1688–90.

    Article  PubMed Central  PubMed  Google Scholar 

  33. Burgos LG, Ebert TJ, Assiddao C, et al. Increased intraoperative cardiovascular morbidity in diabetics with autonomic neuropathy. Anesthesiology. 1989;70:591–7.

    Article  CAS  PubMed  Google Scholar 

  34. Kitamura A, Hoshino T, Kon T, et al. Patients with diabetic neuropathy are at risk of a greater intraoperative reduction in core temperature. Anesthesiology. 2000;92:1311–8.

    Article  CAS  PubMed  Google Scholar 

  35. Boyd GL, Taylor JA, Ovalle F, Stout DG, Aultman M, Garner VM, Morris RE, Witherspoon CD, Albert M, Vetter TR. Prevalence of advanced autonomic dysfunction in patients presenting for retinal surgery. Anesthesiology. 2014. Accepted.

    Google Scholar 

  36. Vinik AI, Suwanwalaikorn S, Stansberry KB, et al. Quantitative measurement of cutaneous perception in diabetic neuropathy. Muscle Nerve. 1995;18:574–84.

    Article  CAS  PubMed  Google Scholar 

  37. Vinik AI, Erbas T, Casellini CM. Diabetic cardiac autonomic neuropathy, inflammation and cardiovascular disease. J Diabetes Investig. 2013;4(1):4–18.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  38. Akselrod S, Gordon S, Ubel FA, Shannon DC, Berger AC, Cohen RJ. Power spectrum analysis of heart rate fluctuations: a quantitative probe of beat-to- beat cardiovascular control. Science. 1981;213:213–20.

    Article  Google Scholar 

  39. Vinik AI, Aysin B, Colombo J. Differentiation of autonomic dysfunction by enhanced frequency domain analysis reveals additional stages in the progression of autonomic decline in diabetics. Diabetes Technology Conference, San Francisco, 10–12 Nov 2005.

    Google Scholar 

  40. Low PA, editor. Clinical autonomic disorders: evaluation and management. Philadelphia: Lippincott-Raven; 1997.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Colombo, J., Arora, R., DePace, N.L., Vinik, A.I. (2015). Autonomic Dysfunction Versus Neuropathy. In: Clinical Autonomic Dysfunction. Springer, Cham. https://doi.org/10.1007/978-3-319-07371-2_13

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-07371-2_13

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-07370-5

  • Online ISBN: 978-3-319-07371-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics